Position in RPRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,449,845
+$307,261 QoQ
Shares Held
30,224
+2.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $117,481,189 across 42 Biotechnology names. RPRX ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
106,893 | $47,732,000 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,517 | $32,850,334 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,472 | $9,751,400 | |
| 4 | INSM |
INSMED Inc
|
48,193 | $7,880,519 | |
| 5 | INCY |
Incyte Corp
|
42,643 | $4,013,559 | |
| 6 | MRNA |
Moderna, Inc.
|
78,526 | $3,989,120 | |
| 7 | TECH |
BIO-TECHNE Corp
|
34,856 | $1,821,574 | |
| 8 | RPRX |
Royalty Pharma plc
This page
|
30,224 | $1,449,845 |
All Filings in RPRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,449,845 | 30,224 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,142,584 | 29,570 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,041,712 | 29,527 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,059,498 | 29,406 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $842,751 | 27,072 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $666,295 | 26,119 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $709,824 | 25,091 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $637,784 | 24,186 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $353,780 | 11,649 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $333,119 | 11,859 | Shares | Sole | 2024-02-13 | |
| 2022-12-31 | $559,484 | 14,157 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,039,295 | 25,866 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,085,472 | 25,820 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,042,218 | 26,751 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,062,361 | 26,659 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $878,780 | 24,316 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $952,853 | 23,246 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,013,772 | 23,241 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||